Related references
Note: Only part of the references are listed.The WOVEN trial: Wingspan One-year Vascular Events and Neurologic Outcomes
Michael J. Alexander et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2021)
Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment
Wu-qiang Che et al.
JOURNAL OF VASCULAR SURGERY (2018)
Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis
Vivek H. Tank et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2016)
Effect of a Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients With Symptomatic Intracranial Stenosis The VISSIT Randomized Clinical Trial
Osama O. Zaidat et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Solving the Issue of Restenosis After Stenting of Intracranial Stenoses: Experience with Two Thin-Strut Drug-Eluting Stents (DES)-Taxus Element™ and Resolute Integrity™
Wiebke Kurre et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Elective treatment of intracranial stenosis with the balloon-expandable Pharos Vitesse stent: 30-day stroke rate and complications
Patrick von Schoenfeldt et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2015)
Bare Metal vs. Drug-Eluting Stents for Extracranial Vertebral Artery Disease: A Meta-Analysis of Nonrandomized Comparative Studies
Nicolas Langwieser et al.
JOURNAL OF ENDOVASCULAR THERAPY (2014)
Higher Risk of Recurrent Ischemic Events in Patients With Intracranial In-Stent Restenosis
Min Jin et al.
STROKE (2013)
Angioplasty and Stenting of Symptomatic Vertebral Artery Stenosis Clinical and Angiographic Follow-up of 206 Cases from Northwest Iran
R. Mohammadian et al.
NEURORADIOLOGY JOURNAL (2013)
Outcomes of Endovascular Treatments of Aneurysms: Observer Variability and Implications for Interpreting Case Series and Planning Randomized Trials
E. Tollard et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Drug-Eluting vs. Bare Metal Stents for Symptomatic Vertebral Artery Stenosis
Lipo Song et al.
JOURNAL OF ENDOVASCULAR THERAPY (2012)
Drug Eluting Stents for Symptomatic Intracranial and Vertebral Artery Stenosis
J. D. Fields et al.
INTERVENTIONAL NEURORADIOLOGY (2011)
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])
Peter Carson et al.
AMERICAN HEART JOURNAL (2010)
Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis
Sabareesh K. Natarajan et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2010)
A Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis
Klaus Groeschel et al.
STROKE (2009)
Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation
Rishi Gupta et al.
STROKE (2006)
Drug-eluting stents for the treatment of intracranial atherosclerosis - Initial experience and midterm angiographic follow-up
A Abou-Chebl et al.
STROKE (2005)
Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA) study results
HL Lutsep et al.
STROKE (2004)
Share Paper
